12 Marijuana Stocks to Buy Now in 2020

There are now more than 50 publicly-traded companies operating in the cannabis industry. Most of these companies aren't directly growing and selling marijuana themselves, but they do stand to benefit greatly as more states legalize the sale and possession of marijuana. Some of these marijuana stocks are media companies. Others are privately studying the medical uses of marijuana. Yet others are providing tools and software for marijuana growers. As more cannabis companies file IPOs and enter the stock market, it will become increasingly difficult for investors to identify which marijuana stocks will truly benefit from the cannabis boom.

Our subscribers have begun digging through these companies, checking out their financials, business models and long-term growth prospects. They know that some "marijuana stocks" are just empty shell companies that deserve to be penny stocks, but they also recognize there are some legitimate and growing companies that truly stand to benefit from the green rush. As a group, they have added 10 different cannabis stocks to their watchlists and are actively investing in them. More than 1,400 MarketBeat subscribers are now following our top-trending cannabis company.

This slide show lists the 12 pot stocks that MarketBeat subscribers are have added to their watchlists and are actively monitoring.

#1 - Canopy Growth (NYSE:CGC)

MarketBeat Followers: 8,500
Market Cap: $5.31 billion
Consensus Rating: Hold
Rating Score: 2.1
Ratings Breakdown: 5 Buy Ratings, 13 Hold Ratings, 3 Sell Ratings.
Consensus Price Target: $28.69 (101.0% Upside)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. Read More 


#2 - Canopy Growth (TSE:WEED)

MarketBeat Followers: 2,597
Market Cap: C$7.06 billion
Consensus Rating: Hold
Rating Score: 2.4
Ratings Breakdown: 4 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: C$28.72 (51.1% Upside)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. Read More 

#3 - Terra Tech (OTCMKTS:TRTC)

MarketBeat Followers: 1,426
Market Cap: $15.35 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Terra Tech Corp. operates as a vertically integrated cannabis-focused agriculture company. The company operates in three segments: Herbs and Produce Products; Cannabis Dispensary, Cultivation and Production; and Real Estate and Construction. The Herbs and Produce Products segment offers hydroponic herbs and leafy greens products. Read More 

#4 - Innovative Industrial Properties (NYSE:IIPR)

MarketBeat Followers: 1,217
Market Cap: $2.59 billion
Consensus Rating: Buy
Rating Score: 2.8
Ratings Breakdown: 5 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $130.00 (9.0% Upside)

Innovative Industrial Properties, Inc is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017.

#5 - Cannabis Science (OTCMKTS:CBIS)

MarketBeat Followers: 1,152
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Cannabis Science, Inc, together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. Read More 

#6 - 22nd Century Group (NYSEAMERICAN:XXII)

MarketBeat Followers: 1,114
Market Cap: $78.47 million
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

22nd Century Group, Inc, a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM research cigarettes for use in independent clinical studies. Read More 

#7 - OrganiGram (TSE:OGI)

MarketBeat Followers: 1,074
Market Cap: C$276.20 million
Consensus Rating: Hold
Rating Score: 2.4
Ratings Breakdown: 4 Buy Ratings, 5 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: C$3.96 (179.2% Upside)

OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. Read More 

#8 - KushCo (OTCMKTS:KSHB)

MarketBeat Followers: 996
Market Cap: $69.80 million
Consensus Rating: Buy
Rating Score: 2.8
Ratings Breakdown: 5 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $4.60 (728.8% Upside)

KushCo Holdings, Inc engages in the wholesale distribution of packaging supplies and customized branding solutions in the United States, Canada, and Europe. It offers pop-top bottles; child resistant exit, paper exit, and foil barrier bags; tubes; and polystyrene, silicone-lined polystyrene, and glass containers. Read More 

#9 - Medical Marijuana (OTCMKTS:MJNA)

MarketBeat Followers: 767
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Medical Marijuana, Inc, an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. Read More 

#10 - Marijuana Company Of America (OTCMKTS:MCOA)

MarketBeat Followers: 641
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Marijuana Company of America, Inc, through its subsidiaries, develops, manufactures, and sells industrial hemp derived and non-psychoactive cannabinoids consumer products under the hempSMART brand in the United States and Canada. The company's principal products include hempSMART Brain, a personal care consumer product that supports brain wellness; hempSMART Pain, a capsule for the temporary relief of minor discomfort associated with physical activity; hempSMART Pain Cream, a wellness consumer product that reduces minor discomfort and promotes muscle relaxation on areas that it is applied; hempSMART Drops; and hempSMART Pet Drops for cats and dogs. Read More 

#11 - Cannabis Sativa (OTCMKTS:CBDS)

MarketBeat Followers: 528
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Cannabis Sativa, Inc, through its subsidiaries, develops, manufactures, and sells herbal based skin care products in the United States and internationally. The company offers Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. Read More 

#12 - United Cannabis (OTCMKTS:CNAB)

MarketBeat Followers: 477
Market Cap: $694,000.00
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

United Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy. Read More 

 

Top Ten Brokerages You Can Trust

There are more than 500 brokerages and research houses that hire analysts to issue ratings and recommendations. Collectively, these brokerages and their analysts publish approximately 175,000 ratings each year. Every trading day, there are nearly 700 reports and recommendations that are released to the public. To say that it's difficult to separate the signal from the noise when interpreting this data would be an understatement.

MarketBeat has developed a system to track each brokerage and research house's stock recommendations and score them based on their past performance. If Goldman Sachs predicted that Apple's stock price was going to hit $150.00 on a specific date, how accurate were they? If Bank of America issued a "strong buy" rating on a stock, how did that stock perform compared to the broader market over the following twelve months. This tracking system has been applied to the 650,000+ ratings that MarketBeat has tracked during the last five years to identify which brokerages you can really trust (and which you can safely ignore).

This slide show lists the 10 brokerages who have issued the most accurate analyst recommendations over the past several years, as measured by the performance of their "buy" ratings and the accuracy of their price targets.

View the "Top Ten Brokerages You Can Trust" Here.